Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pyxis Oncology, Inc.

1.26
+0.160014.55%
Volume:1.29M
Turnover:1.60M
Market Cap:77.60M
PE:-0.95
High:1.33
Open:1.10
Low:1.10
Close:1.10
Loading ...

Will Pyxis Oncology (NASDAQ:PYXS) Spend Its Cash Wisely?

Simply Wall St.
·
23 Feb

Pyxis Oncology initiates new PYX-201 trial, initiates cohort expansions

TIPRANKS
·
04 Feb

Pyxis Oncology Initiates New Pyx-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial

THOMSON REUTERS
·
04 Feb

Pyxis Oncology’s Strategic Focus on PYX-201 and Collaboration with Merck Drives Buy Rating

TIPRANKS
·
21 Dec 2024

Strategic Focus on PYX-201 Drives Positive Buy Rating for Pyxis Oncology

TIPRANKS
·
21 Dec 2024

Pyxis Oncology price target lowered to $5 from $7 at H.C. Wainwright

TIPRANKS
·
20 Dec 2024

Pyxis Oncology, Inc. : H.c. Wainwright Cuts Target Price to $5 From $7

THOMSON REUTERS
·
20 Dec 2024

Pyxis Oncology Price Target Cut to $8.00/Share From $10.00 by RBC Capital

Dow Jones
·
20 Dec 2024

RBC Cuts Price Target on Pyxis Oncology to $8 From $10, Keeps Outperform, Speculative Risk

MT Newswires Live
·
20 Dec 2024

Pyxis Oncology price target lowered to $8 from $10 at RBC Capital

TIPRANKS
·
20 Dec 2024

Pyxis Oncology to Focus on PYX-201, Suspends PYX-106 Program

Dow Jones
·
20 Dec 2024

Pyxis Oncology to Focus Resources on Lead Clinical Program PYX-201

MT Newswires Live
·
20 Dec 2024

BRIEF-Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources On Its Lead Clinical Program, Pyx-201

Reuters
·
20 Dec 2024

Pyxis Oncology to prioritize PYX-201, suspends investment in PYX-106

TIPRANKS
·
20 Dec 2024

Pyxis Oncology Shares up 5.2% at $1.62 After the Bell Following Announcement of Portfolio Prioritization

THOMSON REUTERS
·
20 Dec 2024

Refile- Pyxis Oncology- Company to Focus on Advancing Lead Asset, Pyx-201 (Adds Dropped Words)

THOMSON REUTERS
·
20 Dec 2024

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on Its Lead Clinical Program, Pyx-201

THOMSON REUTERS
·
20 Dec 2024

Pyxis Oncology Inc - - Company

THOMSON REUTERS
·
20 Dec 2024

Pyxis Oncology Inc - Current Cash Runway Expected to Fund Development Into 2H 2026

THOMSON REUTERS
·
20 Dec 2024

CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares

Simply Wall St.
·
01 Dec 2024